Few Worries About Genetic Testing

October 19, 2012
A common refrain for critics of direct to consumer genetic testing is that the tests could cause unnecessary worry. Those critics believe that for some tests the results shouldn’t go...
Read More

23andMe Goes to Washington

October 17, 2012
As we near our goal of enrolling 10,000 patients in 23andMe’s Parkinson’s research community, we are ever more eager to share what we are doing. Last month our CEO, Anne...
Read More

Using Genetics and Family History for Health

October 15, 2012
For decades, a patient’s family health history has been a keystone to any wellness plan. A simple record of medical conditions your siblings, your parents, aunts, uncles and grandparents struggled...
Read More

Novel Genetic Findings for Myeloproliferative Neoplasms

October 12, 2012
Dave Hinds is a Principal Scientist in Statistical Genetics.   Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. 23andMe is passionate about...
Read More

More On 23andMe’s Neanderthal Lab

October 11, 2012
Not everyone would embrace their inner caveman, but in today’s Slate Ann Gibbons sure did. Gibbons, who also writes for Science, is the author of the book The First Human:...
Read More

The Genetics of Nearsightedness, Stretch Marks, and Motion Sickness

October 09, 2012
Amy Kiefer is a Survey Research Manager at 23andMe. She joined the company in 2008. What do nearsightedness, stretch marks, and motion sickness have to do with each other? They...
Read More

Chocolate Broccoli

October 05, 2012
Ever since my kids were wee tykes in diapers, I’ve gone through the same bedtime routine of reading them a story. We went from picture books to the simple joys...
Read More

Fear Not The Genome

October 03, 2012
We would like to give a little shout-out to Holly Dunsworth, an assistant professor of anthropology at the University of Rhode Island and a blogger, for her thoughtful post “Be...
Read More

Blood Thinners and the Genetics Behind Drug Response

October 02, 2012
A study in the journal Lancet regarding a new blood thinning drug brings to mind the difficulty doctors and patients have in using anticoagulants to prevent clots that could otherwise...
Read More

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

October 01, 2012
Ashley Gould, 23andMe’s Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative...
Read More